Flowerbed-inspired biomimetic 3D-printed scaffolds functionalized with urine-derived stem cell exosomes promote alveolar bone regeneration by regulating energy metabolism
Theranostics · 2026-01-14 · 16 (7) · 3826-3856
DOI: 10.7150/thno.123700 ↗At a glance
Journal article in Theranostics, published on 2026-01-14. Written by Yanxi Chen and 6 co-authors. Institution: The Affiliated Stomatological Hospital of Chongqing Medical University, Chongqing, China. Major MEDLINE topics: Bone Regeneration, Exosomes, Tissue Scaffolds, Energy Metabolism. Cited 9 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Rationale
The anatomical complexity and restricted regenerative potential of alveolar bone defects create a significant clinical challenge and highlight the need for spatially biomimetic and biologically supportive biomaterials.
Methods
We developed a bone-mimicking matrix hydrogel scaffold inspired by the features of a "flowerbed," utilizing machine learning-guided three-dimensional bioprinting. Gelatin methacrylate (GelMA), decellularized bone matrix (DBM), and urine-derived stem cell exosomes (USC-Exos) were co-integrated during the printing process to deliver crucial biophysical and biochemical signals for bone regeneration.
Results
The GelMA/DBM/USC-Exos scaffold exhibited high printing fidelity, enabling precise fabrication of defect-specific geometries while preserving exosome bioactivity and achieving sustained release (> 16 days). Functionally, the scaffold promoted M2 macrophage polarization and markedly upregulated osteogenic and angiogenic gene expression, which was approximately 2-fold higher than that of the control (p < 0.01). Mechanistically, the scaffold enhanced oxidative phosphorylation by activating the AMP-activated protein kinase pathway, resulting in a nearly 2-fold increase in adenosine triphosphate content and promoting the osteogenic differentiation of jawbone marrow-derived mesenchymal stem cells. In vivo implantation in mandibular defect models induced robust neovascularization and bone formation, resulting in a nearly 3-fold increase in vessel density and 65.6 ± 3.0% new bone volume after 4 and 8 weeks, respectively, effectively promoting coordinated and functional alveolar bone regeneration.
Conclusions
This study establishes a biomimetic approach that integrates structural biomimicry, exosome-mediated bioactivity, and energy metabolism regulation, offering a promising and targeted strategy for personalized alveolar bone regeneration.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- The Affiliated Stomatological Hospital of Chongqing Medical University, Chongqing, China.
- Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing, China.
- Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, China.
- Chongqing Municipal Health Commission Key Laboratory of Oral Biomedical Engineering, Chongqing, China.
Cite
APA
Chen, Y., Yang, X., Zhang, Y., Yang, M., Dai, H., Li, J., & Zhou, J. (2026). Flowerbed-inspired biomimetic 3D-printed scaffolds functionalized with urine-derived stem cell exosomes promote alveolar bone regeneration by regulating energy metabolism. Theranostics, 16(7), 3826-3856. https://doi.org/10.7150/thno.123700
Vancouver
Chen Y, Yang X, Zhang Y, Yang M, Dai H, Li J, et al. Flowerbed-inspired biomimetic 3D-printed scaffolds functionalized with urine-derived stem cell exosomes promote alveolar bone regeneration by regulating energy metabolism. Theranostics. 2026;16(7):3826-3856. doi:10.7150/thno.123700
BibTeX
@article{Chen2026,
author = {Chen, Yanxi and Yang, Xiuyuan and Zhang, Yuxin and Yang, Min and Dai, Hongwei and Li, Jie and Zhou, Jianping},
title = {Flowerbed-inspired biomimetic 3D-printed scaffolds functionalized with urine-derived stem cell exosomes promote alveolar bone regeneration by regulating energy metabolism},
journal = {Theranostics},
year = {2026},
volume = {16},
number = {7},
pages = {3826--3856},
doi = {10.7150/thno.123700}
}
EUVIMED